Cost-effectiveness of long-term intrathecal morphine therapy for pain associated with failed back surgery syndrome

Clinical Therapeutics

Volumn 19, Issue 1, 1997, Pages 96-112

  De Lissovoy, Gregory ^a   Brown, Ruth E ^b   Holpern, Michael ^a   Hassenbusch, Samuel J ^c   Ross, Edgar ^d  

^a UNITED BIOSOURCE CORPORATION   (United States)

^b MEDTAP International Inc   (United Kingdom)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Meridia Ctr Rehab and Pain Mgmt   (United States)

Author keywords

cost effectiveness; failed back surgery syndrome; intrathecal morphine therapy

Indexed keywords

MORPHINE;

ARTICLE; BACKACHE; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DECISION THEORY; HEALTH INSURANCE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; LONG TERM EXPOSURE; MINIPUMP; SIDE EFFECT; SURGERY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030956562     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80077-X     Document Type: Article

References (28)

1. Leitman R, Binns K, Unni A. National Pain Survey (Study No. 942004). New York: Louis Harris and Associates; 1994.
2. Frymoyer JW, Cats-Baril WL. An overview of the incidences and costs of low back pain. Orthop Clin North Am. 1991; 22;263-271.
3. National Center for Health Statistics. 1990 National Hospital Discharge Survey. Report no. PB 92-500818. Washington, DC: US Department of Health and Human Services, Centers for Disease Control; 1990.
4. Bedder MD, Burchiel K, Larson A. Cost analysis of two implantable narcotic delivery systems. J Pain Symptom Manage. 1991;6:368-373.
5. Hillman AL, Eisenberg JM, Pauly MV, et al. Avoiding bias in the conduct of and reporting of cost-effectiveness research sponsored by pharmaceutical companies. NEJM. 1991;324:1362-1365.
6. Merskey H, Bogduk N, eds. Task Force on Taxonomy of the International Association for the Study of Pain: Classification of Chronic Pain. Seattle: IASP Press; 1994.
7. Paice JA, Magolan JM. Intraspinal drug therapy. Nurs Clin North Am. 1991;26: 477-498.
8. Krames ES. Intrathecal infusional therapies for intractable pain: Patient management guidelines. J Pain Symptom Manage. 1993;9:36-46.
9. Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: Analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage. 1993;3:539-548.
10. Paice JA, Penn RD, Ryan WG. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids. J Pain Symptom Manage. 1994;9:126-131.
11. Hassenbusch SJ, Pillay PK, Magdinec M, et al. Constant infusion of morphine for intractable cancer pain using an implanted pump. J Neurosurg. 1990;73:405-409.
12. Data on file. Paice JA, Penn RD, Shott S. Intrathecal morphine for chronic pain: A retrospective, multi-center study. Department of Neurosurgery, Rush Medical Center, Chicago, Illinois, 1994.
13. Data on file. Medtronic, Inc., Neurological Division. Returned Product Analysis, Minneapolis, Minnesota, 1994.
14. Data on file. Hassenbusch SJ, Payne R, Paice JA, et al. Charge modeling of opioid therapy via different delivery routes for cancer pain management. Report by Department of Neurosurgery, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, 1994.
15. Physician Payment Review Commission. Annual Report to Congress: 1994. Washington, DC: Physician Payment Review Commission, 1995.
16. Red Book. 1994 Drug Topics. Montvale, NJ: Medical Economics Publishing Co.; 1994.
17. Ferrell BR, Griffith H. Cost issues related to pain management: Report from the cancer pain panel of the Agency for Health Care Policy and Research. J Pain Symptom Manage. 1994;9:221-234.
18. Turk DC, Rudy TE, Sorkin BA. Neglected topics in chronic pain treatment outcome studies: Determination of success. Pain. 1993;53:3-16.
19. North RB, Campbell JN, James CS, et al. Failed back surgery syndrome: 5-year follow-up in 102 patients undergoing repeated operation. Neurosurgery. 1991;28: 685-691.
20. Loeser JD, Bigos SJ, Fordyce WE, Volinn EP. Low back pain. In: Bonica JJ, ed. The Management of Pain. Philadelphia: Lea & Febiger; 1990:1472.
21. Current Procedural Terminology. Chicago: American Medical Association; 1995.
22. Graham AA, Holohan TV. External and implantable infusion pumps. Health Technology Review 7. Rockville, Md: US Department of Health and Human Services, Agency for Health Care Policy and Research, 1993.
23. Agency for Health Care Policy and Research (AHCPR). Management of cancer pain: Adults. Practice Guidelines Quick Reference Guide for Clinicians No. 9. Rockville, Md: US Department of Health and Human Services, Public Health Service, March 1994.
24. Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine. 1985;10: 779-781.
25. Cousins MJ, Plummer JL. Spinal opioids in acute and chronic pain. In: Max MB, Portenoy RK, Laska EM, eds. Advances in Pain Research and Therapy. The Design of Analgesic Clinical Trials. Vol. 18. New York: Raven Press; 1991:457-479.
26. Talo S, Puukka P, Rytokoski U, et al. Can treatment outcome of chronic low back pain be predicted? Psychological disease consequences clarifying the issue. Clin J Pain. 1994;10:107-121.
27. Brose WG. Health outcomes. Clin J Pain. 1994;10:89-94. Editorial.
28. Deyo RA. Low back pain. Adv Pain Res Ther. 1991;18:291-303.